Lilly drug fails in breast cancer trial, shares fall

The drug, ramucirumab, has been successful in gastric cancer trials and is also being tested for colon, liver and lung cancers, with key late stage data on those three expected next year.

http://au.news.yahoo.com/thewest/business/a/-/world/19131507/lilly-drug-fails-in-breast-cancer-trial-shares-fall/